Guru Ownership Trend
Guru Analysis for Monte Rosa Therapeutics, Inc. (GLUE)
Monte Rosa Therapeutics, Inc. (GLUE), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $32.55 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $10.82 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, Cliff Asness reduced exposure by 16.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Monte Rosa Therapeutics, Inc. (GLUE)
Major holders include Cliff Asness ($10.83 M), Renaissance Technologies (RenTech) ($6.24 M), Ken Fisher ($5.18 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.44 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $10.82 M, with 4 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited GLUE. The total reported sell value was $2.08 M.
Yes, 4 managers opened new positions in GLUE, and 0 increased their existing holdings. The total reported buy value was $12.9 M.